Emma

Snapes

Editor-in-Chief

International Society for Biological and Environmental Repositories (ISBER)

"Unlocking Value: Standards in Biopharma and the Lifesciences"Emma is a biobanking consultant with 25 years of expertise in the creation and management of biological and data collections across various sectors, including clinical, academic, semi-state, and commercial. Her expertise spans different species, such as human, plant, and microbial and she works with diverse groups to ensure the sustainability of biobanking as an integral component of translational research. Emma's passion for advancing resilience in the biobanking sector is evident in her solution-oriented mindset. Her notable achievements include receiving recognition and an NSAI award for her instrumental role in the development of ISO biobanking standards. Most recently, as the Editor-in-Chief of ISBER Best Practices Fifth Edition, she collaborates with others worldwide to ensure that innovative solutions and hard-won knowledge are presented as recommended practices for the global biobanking community. She received the ISBER Special Services Award in May 2023 in recognition of her exceptional contributions. She is also involved in other national and international initiatives aimed at improving biobanking practices. Emma invites you to connect with her on LinkedIn. Bio Summary: Emma Snapes is a visionary leader at the forefront of the biobanking industry, renowned for her unwavering dedication, innovation, and transformative impact. With over 25 years of experience spanning microbiology, biotechnology, and various sectors, Emma has emerged as a driving force for positive change in biobanking practices worldwide. Recognized for her instrumental role in shaping international standards and best practices, Emma's passion for excellence and commitment to advancing fit-for-purpose biobanking are unparalleled. Her visionary leadership has been instrumental in working together with diverse stakeholders to develop ground breaking standards such as ISO 20387:2018, revolutionizing the biobanking landscape and for global consistency and quality. Emma's exceptional leadership and outstanding teamwork have been

Panel Sypnosis

"Unlocking Value: Standards in Biopharma and the Lifesciences"As the biopharma industry navigates the rigorous terrain of regulatory compliance, the role of voluntary standards, such as those set forth by the International Standardization Organization (ISO), often remains underutilized yet powerful in fostering quality, innovation, and long-term resilience. This session, co-presented by a representative from the National Standards Authority of Ireland and an expert and assessor in biobanking and ISO biotechnology standards, will shed light on the strategic benefits that standards can bring beyond baseline compliance. Relevant standard developments for biopharma and lifescience will be highlighted e.g., ISO 20387 for biobanking, ISO 14644 series for cleanrooms, emphasizing how standards can enhance operational effectiveness and optimize bioprocessing. Engaging in standard development is a great way to keep up to date on new developments relevant to the Biopharma and lifescience sector. Participants will leave equipped with practical approaches on how to keep up to date on relevant sector standards and how to integrate voluntary standards as a strategic resource for future-proofing operations.